The top 15 drug patent expirations of 2018
Each year, dozens of branded pharmaceutical products lose their patent protections, paving the way for cheaper generics. FiercePharma compiled this report with info from many different sources in order to forecast the largest patent expirations for 2018. Check out this year’s list below:
- Rituxan
- Neulasta
- Lyrica
- Advair
- Xolair
- Epogen/Procrit
- Restasis
- Cialis
- Sensipar
- Zytiga
- Letairis
- Remodulin
- NuvaRing
- Ampyra
- Namenda XR
